| Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems A Sarandol, E Sarandol, SS Eker, S Erdinc, E Vatansever, S Kirli Human Psychopharmacology: Clinical and Experimental 22 (2), 67-73, 2007 | 532 | 2007 |
| Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study VO Kotan, E Sarandol, E Kirhan, G Ozkaya, S Kirli Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (5), 1284-1290, 2011 | 163 | 2011 |
| The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study EY Sivrioglu, S Kirli, D Sipahioglu, B Gursoy, E Sarandöl Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (7), 1493-1499, 2007 | 129 | 2007 |
| Oxidative–antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment A Sarandol, S Kirli, C Akkaya, A Altin, M Demirci, E Sarandol Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (6), 1164-1169, 2007 | 112 | 2007 |
| A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia S Kirli, M Çaliskan Schizophrenia research 33 (1-2), 103-111, 1998 | 91 | 1998 |
| Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder A Sarandol, E Sarandol, SS Eker, EU Karaagac, BZ Hizli, M Dirican, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (6), 1103-1108, 2006 | 81 | 2006 |
| Şizofreni Hastalarında Bakım Veren Külfet Düzeyinin, Sosyodemografik Değişkenler ve Hastalığın Özellikleri ile İlişkisi. A AYDIN, SS EKER, Ş CANGÜR, A SARANDÖL, S KIRLI Archives of Neuropsychiatry/Noropsikiatri Arsivi 46, 2009 | 62 | 2009 |
| Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder SS Eker, C Akkaya, A Sarandol, S Cangur, E Sarandol, S Kirli Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (4), 955-961, 2008 | 58 | 2008 |
| Increased plasma agmatine levels in patients with schizophrenia T Uzbay, G Goktalay, H Kayir, SS Eker, A Sarandol, S Oral, L Buyukuysal, ... Journal of psychiatric research 47 (8), 1054-1060, 2013 | 55 | 2013 |
| Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment A Sarandol, S Kirli, C Akkaya, N Ocak, E Eroz, E Sarandol Journal of psychopharmacology 21 (8), 857-863, 2007 | 48 | 2007 |
| Reliability and validity of the Geriatric Depression Scale in detection of poststroke minor depression EY Sivrioglu, K Sivrioglu, T Ertan, FS Ertan, E Cankurtaran, O Aki, ... Journal of Clinical and Experimental Neuropsychology 31 (8), 999-1006, 2009 | 47 | 2009 |
| Sosyal uyum kendini değerlendirme ölçeği (SUKDÖ) Türkçe formunun geçerlik ve güvenilirliği C Akkaya, A Sarandöl, AE Danaci, EY Sivrioğlu, E Kaya, S Kirli Türk Psikiyatri Dergisi 19 (3), 292-299, 2008 | 41 | 2008 |
| Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition EY Sivrioglu, VC Topaloglu, A Sarandol, C Akkaya, SS Eker, S Kirli Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2), 548-550, 2007 | 33 | 2007 |
| Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder SS Eker, C Akkaya, S Akgöz, A Sarandöl, S Kirli Turk Psikiyatri Dergisi= Turkish Journal of Psychiatry 16 (3), 153-163, 2005 | 33 | 2005 |
| Examining Cut-Off Values for the State-Trait Anxiety Inventory/Examinando los puntajes de corte para el inventario de ansiedad estado-rasgo I Ercan, S Hafizoglu, G Ozkaya, S Kirli, E Yalcintas, C Akaya Revista Argentina de Clinica Psicologica 24 (II), 143, 2015 | 29 | 2015 |
| A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis C Akkaya, A Sarandol, EY Sivrioglu, Z Kotan, S Kirli Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (8), 1535-1538, 2006 | 27 | 2006 |
| Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases C Akkaya, B Kaya, Z Kotan, A Sarandol, C Ersoy, S Kirli Journal of Psychopharmacology 23 (6), 723-726, 2009 | 24 | 2009 |
| Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study C Akkaya, EY Sivrioglu, S Akgoz, SS Eker, S Kirli Human Psychopharmacology: Clinical and Experimental 21 (5), 337-345, 2006 | 23 | 2006 |
| Addiction to topically used cyclopentolate hydrochloride: a case report C Akkaya, SZ Kocagoz, A Sarandol, SS Eker, S Kirli Progress in neuro-psychopharmacology & biological psychiatry 32 (7), 1752-1753, 2008 | 16 | 2008 |
| Şizofreni hastaları ve yakınlarıyla yapılan sanatla terapinin hastalık belirtileri, bireysel ve toplumsal beceriler üzerine etkisi. A SARANDÖL, C Akkaya, N Eracar, S Kirli Anatolian Journal of Psychiatry/Anadolu Psikiyatri Dergisi 14 (4), 2013 | 15 | 2013 |
